Sunday Poster Session
Category: Biliary/Pancreas
Thomas Tielleman, MD
University of Texas Southwestern Medical Center
Dallas, TX
| Single stent, n=51 | Double stents, n=16 | P value | Total, n=76 |
Age, mean (SD) | 69.6 (12.8) | 69.6 | 0.65 | 69 (12.7) |
Female, n (%) | 6 (11.8) | 4 (25) | 0.2 | 10 (13.2) |
CBD stone present, n (%) | 20 (39.2) | 6 (37.5) | 0.9 | 49 (64.5) |
Indication, n (%) |
|
|
|
|
Reason for nonoperative status |
|
| 0.27 |
|
Poor functional status | 6 (11.8) | 2 (13.3) |
| 10 (13.3) |
Comorbidities | 21 (41.2) | 6 (40) |
| 33 (44) |
Advanced malignancy | 5 (9.8) | 1 (6.7) |
| 6 (8) |
Anticipated challenging surgery | 15 (29.4) | 2 (13.3) |
| 17 (22.7) |
Multifactorial | 4 (7.8) | 5 (31.2) |
| 10 (13.2) |
Cystic duct balloon dilation before placement, n (%) | 29 (56.9) | 12 (75) | 0.19 | 43.4 (76) |
Prior percutaneous drain, n (%) | 4 (7.8) | 8 (50) | < 0.001 | 13 (17.1) |
Diameter of the 1st stent, n (%) |
|
| 0.06 |
|
5 Fr | 3 (5.9) | 0 (0) |
| 3 (4.5) |
7 Fr | 29 (56.9) | 15 (93.7) |
| 44 (65.7) |
8.5 Fr | 10 (19.6) | 1 (6.3) |
| 11 (16.4) |
10 Fr | 9 (17.6) | 0 (0) |
| 9 (13.4) |
Clinical success, n (%) | 45 (88.2) | 15 (93.7) | 0.53 | 61 (81.3) |
Unplanned reintervention, n (%) | 11 (21.6) | 0 (0) | 0.04 | 11 (14.5) |
Adverse event, n (%) | 4 (7.8) | 1 (6.3) | 0.83 | 5 (7.5) |
Cholangitis, n (%) | 0 (0) | 0 (0) | - | 0 (0) |
Perforation, n (%) | 0 (0) | 0 (0) | - | 0 (0) |
Post-ERCP pancreatitis, n (%) | 2 (3.9) | 1 (6.3) | 0.69 | 3 (4) |